The antiestrogen LY117018 is estrogenic in the fetal rat.
LY117018 (LY) has high affinity for the adult rat uterine estrogen receptor, has little uterotrophic activity, and inhibits many estradiol (E2)-induced responses in the adult or immature uterus. In these studies, LY was injected into day 19 rat fetuses, with and without diethylstilbestrol (DES) or E2, to determine whether it could block the estrogen-induced teratogenesis. LY at 1, 25, or 50 micrograms/fetus failed to decrease the 15-70% incidences of oviduct malformation and cleft phallus induced by DES (2.5 micrograms/fetus) or E2 (50 micrograms/fetus). However, LY alone (1-50 micrograms/fetus) was more potent than E2 in eliciting these same urogenital malformations. LY also failed to compete in vitro for plasma protein-bound 3H-E2, and therefore, like DES, is more available than E2 for uptake into fetal tissues. Thus, in the fetus, unlike the adult, LY was an estrogen agonist, which indicates that the fetus has a very different sensitivity than the adult to estrogenic compounds.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001667:Binding, Competitive; D004054:Diethylstilbestrol / Q000633:toxicity; D004958:Estradiol / Q000378:metabolism / Q000633:toxicity; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D005333:Fetus / Q000187:drug effects*; D011247:Pregnancy; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011960:Receptors, Estrogen / Q000378:metabolism; D013723:Teratogens; D013876:Thiophenes / Q000494:pharmacology*
D004965:Estrogen Antagonists; D011759:Pyrrolidines; D011960:Receptors, Estrogen; D013723:Teratogens; D013876:Thiophenes; D004958:Estradiol; C025430:LY 117018; D004054:Diethylstilbestrol